| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 06/21/2001 | WO2001044224A1 Method for preparing dl-alpha-tocopherol with a high yield and high purity |
| 06/21/2001 | US20010004629 Improved toleration by crops, insecticidal and/or spectrum of action |
| 06/20/2001 | EP1108718A2 Trans-6-Acetyl-4S-(4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3R-ol |
| 06/20/2001 | EP0890176B1 Proton conductor in liquid form |
| 06/20/2001 | EP0790990B1 Process for the production of tocopherol and tocopherol/tocotrienol concentrates |
| 06/20/2001 | EP0773794B1 Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1299818A Tea flavone as one flavone compound from tea |
| 06/19/2001 | US6248904 Phthalein dyes |
| 06/19/2001 | US6248777 Vascular disorders |
| 06/19/2001 | US6248341 Method of treating topical angiogenesis-related disorders |
| 06/19/2001 | US6248264 Windows or eyeglass/sunglass lenses having good darkening and lightening performance with high optical density |
| 06/19/2001 | CA2008856C Tocols as adjuvant in vaccine |
| 06/14/2001 | WO2001042237A1 3-methyl-chromane or thiochromane derivatives |
| 06/14/2001 | WO2001042236A1 Metal salts of 3-methyl-chromane or thiochromane derivatives |
| 06/14/2001 | WO2001042235A1 3-ethyl-, 3-propyl- or 3-butyl-chroman and -thiochroman derivatives |
| 06/14/2001 | WO2001042234A1 3-methyl-chroman and -thiochroman derivatives |
| 06/14/2001 | WO2001042233A1 Optically active chroman and thiochroman derivatives |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042211A2 Detection of transmembrane potentials by optical methods |
| 06/14/2001 | WO2001041775A2 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
| 06/14/2001 | WO2001041773A1 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | CA2393562A1 Detection of transmembrane potentials by optical methods |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/13/2001 | EP1105385A2 Water-dispersible or water-soluble d-tocotrienol compounds and methods for making therefor |
| 06/13/2001 | EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 06/13/2001 | CN1067066C Process for prepn. of alpha-tocopherol |
| 06/13/2001 | CN1067050C Method for prodn. of 3-alkoxy-2-substituted phenmethyl acid or ester thereof |
| 06/12/2001 | US6245804 Contraceptives; urogenital disorders |
| 06/07/2001 | WO2001040214A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | WO2001040213A1 Neutralizing agent for toxin of microorganism belonging to the genus clostridium |
| 06/07/2001 | WO2001040191A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/07/2001 | WO2001040188A1 Curcumin analogues for treating cancer |
| 06/07/2001 | CA2393440A1 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 06/07/2001 | CA2393026A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | CA2393012A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/06/2001 | EP1104757A1 Sesterterpene derivatives exhibiting antifungal activities |
| 06/06/2001 | EP1104414A1 Enantioselective synthesis |
| 06/06/2001 | CN1298390A Arylphenyl-substituted cyclic keto-enols |
| 06/06/2001 | CN1066625C Therapeutical use for benzopyran derivative |
| 06/05/2001 | US6242495 Compounds and compositions for delivering active agents |
| 06/05/2001 | US6242480 Ophthalmic viscoelastic compositions |
| 06/05/2001 | US6242479 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | US6242227 Method of vitamin production |
| 06/05/2001 | US6242198 Methods of treatment of eye trauma and disorders |
| 06/05/2001 | US6242030 Ginkgo Bilboa flavonoid extract which is terpene-free and has a high flavonoid heteroside content |
| 05/31/2001 | WO2001037983A1 New functionalized polymeric reagents |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | US20010002407 Isolated cherry extract containing anthocyanins, bioflavonoids and phenolics as antiinflammatory and antiarthritic agents; food additives; tablets; enzyme inhibitors |
| 05/31/2001 | DE10054550A1 Novel sulfonium salts with oxoindanyl, tetralonyl or chromanonyl groups are useful as photoacid producers in chemically-amplified positive and negative photoresists processed at far-to-vacuum UV wavelengths |
| 05/31/2001 | CA2389953A1 New functionalized polymeric reagents |
| 05/30/2001 | EP1103550A1 Process for concentrating catechin solutions using membranes |
| 05/30/2001 | EP1102776A1 Water soluble prodrugs of hindered alcohols or phenols |
| 05/30/2001 | EP1102742A2 Compounds and compositions for delivering active agents |
| 05/30/2001 | EP1102535A2 Compounds and methods |
| 05/30/2001 | EP0861242B1 Heterocyclic fungicides |
| 05/30/2001 | EP0623608B1 Benzopyran derivative, production thereof, and pharmaceutical preparation containing the same as active ingredient |
| 05/30/2001 | CN1296948A Synthesis and application of 5,7-dihydroxy-4'-benzyloxyflavanone |
| 05/30/2001 | CN1296947A Derivative of pueraria root-soybean aglycone |
| 05/29/2001 | US6239294 Process to produce α-tocopherol-acetate |
| 05/29/2001 | US6239171 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/29/2001 | US6239169 Non-steroidal polycyclic ring sulphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors |
| 05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
| 05/25/2001 | WO2001036424A2 Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing them |
| 05/25/2001 | WO2001036406A1 Naphthopyrans annelated in c5-c6 with an indene- or dihydronaphthalene-type and compositions and matrices containing them |
| 05/25/2001 | CA2392053A1 Naphthopyrans annelated in c5-c6 with an indene- or dihydronaphthalene-type ring and compositions and matrices containing them |
| 05/25/2001 | CA2390109A1 Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing them |
| 05/24/2001 | US20010001800 The xanthene compound reacts with nitric oxide to give a triazole fluorescent compound that emits strong fluorescence by irradiation with excitation light of long wavelength |
| 05/23/2001 | EP1100769A1 Aminomethylcarboxylic acid derivatives |
| 05/23/2001 | EP1100520A1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 05/23/2001 | EP0788497B1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 05/23/2001 | CN1066055C Productive method for extracting flavonoid compound extract or powder from bamboo leaf |
| 05/22/2001 | US6235785 Methods for identifying and treating resistant tumors |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235774 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration |
| 05/22/2001 | US6235448 Photoresist monomers, polymers thereof, and photoresist compositions containing the same |
| 05/22/2001 | US6235294 Flavonoide esters and their use notably in cosmetics |
| 05/17/2001 | WO2001034592A1 5-halo-4-fluoro-4,7,7-trimethyl-3-oxabicyclo[4.1.0]heptane-2-ones, method for their production and their use in the production of cyclopropane carboxylic acids |
| 05/17/2001 | WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/17/2001 | WO2001034135A2 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | WO2001034116A2 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 05/17/2001 | WO2001014360A3 Benzopyrans and benzothiopyrans as rar selective retinoid agonists |
| 05/17/2001 | DE19954160A1 5-Halo-4-fluor-4,7,7-trimethyl-3-oxabicyclo[4.1.0]heptan-2-one, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Cyclopropancarbonsäuren 5-Halo-4-fluoro-4,7,7-trimethyl-3-oxabicyclo [4.1.0] heptan-2-one, processes for their preparation and their use for the preparation of cyclopropane carboxylic acids |
| 05/17/2001 | CA2390837A1 5-halo-4-fluoro-4,7,7-trimethyl-3-oxabicyclo[4.1.0]heptan-2-ones, process for their preparation and their use for preparing cyclopropanecarboxylic acids |
| 05/17/2001 | CA2390789A1 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | CA2390553A1 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 05/16/2001 | EP1098893A1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | CN1295568A Method for separating a tocotrienol from tocol-containing mixture and compositions thereof |
| 05/16/2001 | CN1065864C Aylucone isoflavone enriched regetable protein whey, whey protein, and process for producing same |
| 05/16/2001 | CA2325734A1 Process for concentrating aqueous epigallocatechin gallate solutions |